Showing results (181-190 of 265) with videos related to

Sort By:
Pageof 27
Journal of Clinical Pathology|June 1, 1988
Cytomegalovirus infections in heart and heart and lung transplant recipientsT G Wreghitt, M Hakim, J J Gray, et al.
Eye (London, England)|January 1, 1995
The control of hyperacute rejection by genetic engineering of the donor speciesD J White, E Cozzi, G Langford, et al.
The European Respiratory Journal|July 1, 1992
Diurnal variation in FEV1 after heart-lung transplantationJ F Morrison, T W Higenbottam, T J Hathaway, et al.
The Journal of Heart Transplantation|May 1, 1990
Histologic prognostic indicators for the lung allografts of heart-lung transplantsC Clelland, T Higenbottam, B Otulana, et al.
European Journal of Nuclear Medicine|January 1, 1982
The use of 111In-labeled lymphocyte imaging to evaluate graft rejection following cardiac transplantation in dogsJ H McKillop, J Wallwork, B A Reitz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 11, 2001
A model for analyzing the cost of the main clinical events after lung transplantationL D Sharples, G J Taylor, J Karnon, et al.
British Journal of Pharmacology|January 1, 1990
Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndromeA T Dinh Xuan, T W Higenbottam, C Clelland, et al.
Transplantation|November 27, 1996
Pharmacodynamics of cyclosporine in heart and heart-lung transplant recipients. II: Blood cyclosporine concentrations and other risk factors for lung allograft rejectionN G Best, K K Tan, A K Trull, et al.
European Heart Journal|April 1, 1992
Late pulmonary haemodynamic changes in heart-lung transplantationJ P Scott, B A Otulana, P A Mullins, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Evaluating the donor pool: impact of using hearts from donors over the age of 49 yearsP Mercer, L Sharples, J Edmunds, et al.
Pageof 27